Brenda Finucane, MS, LGC, is Professor and Associate Director of Geisinger Health System's Autism and Developmental Medicine Institute.  Finucane is a genetic counselor, and her education and career have straddled research and the clinic.  Her clinical and research activities have focused on genetic causes of developmental brain disorders, including autism and intellectual disability.  Finucane's early work focused on the behavioral and cognitive consequences of the fragile X syndrome, Smith-Magenis, and 15q duplication, among other syndromes.  At Geisinger in her current position, Finucane and her team study the family genetic background and its impact on phenotypes for several syndromes including the fragile X syndrome, sex chromosomal abnormalities, and the 22q11.2 deletion syndrome.  Ms. Finucane has a particular interest in translating knowledge about genetic diagnoses into practical strategies that enhance healthcare, behavioral, and educational interventions for children and adults.  She is widely published and has been in leadership roles in professional and advocacy organizations throughout her career, including a term as president of the National Society of Genetic Counselors.